BUZZ-Shire: HBSC sounds caution on Baxalta deal

** Drugmaker Shire down c.2 pct & second biggest loser on the Stoxx 600 healthcare index after HSBC cuts TP on stock to 5400p from 6200p & raises sirens around its proposed $32 billion cash-and-stock…